Post-public health emergency fallout hits patients
Axios· 35 minutes agoCancer doctors and dozens of lawmakers in Congress are questioning whether the federal health department overreached when it blocked medical practices...
Patient Blood Management Market Efficiency, Safety, Success: Unleash the Power of Transfusion...
Digital Journal· 2 hours agoNewark, New Castle, USA new report, titled Patient Blood Management Market The report has been put together using primary and secondary research methodologies, which offer ...
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool· 10 minutes agoIt wasn't because so many patients were newly diagnosed with type 2 diabetes. Instead, Ozempic gained widespread popularity for helping people lose...
With few MDs practicing in rural areas, a different type of doctor is filling the gap
NPR· 1 hour agoDe Regnier is an osteopathic physician who chose to run a family practice in a small community. Many...
Compass Medical announces immediate closure, patients left pondering their healthcare futures
WFXT via Yahoo News· 4 days agoPatients at Compass Medical are confused and looking for answers regarding the future of their local...
U.S. cancer drug shortage forcing doctors to seek other options. Staten Island experts weight in.
Staten Island Advance· 35 minutes agoThe shortages of generic medications being felt across the country have affected the course of treatment of some of the Island’s cancer patients, with alternative treatments ...
Chemo drug shortage pauses Sacramento patient's treatments as cancer grows
MSN News· 6 hours agoA local cancer patient is now patiently waiting as a nationwide shortage in chemotherapy drugs has...
Scientists saw a surge in brain activity in dying patients that could finally help explain...
Business Insider via Yahoo News· 22 hours agoWhat this means for human consciousness is still up for debate.MR.Cole_Photographer/Getty Images...
...Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous...
Morningstar· 31 minutes agoSUZHOU, China, and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that
Rectal Cancer Patients Could Be Spared the Brutal Effects of Radiation
New York Times· 22 hours agoA large “de-escalation” trial suggests that tens of thousands of people annually may be able to rely...